Le Lézard
Classified in: Health, Covid-19 virus
Subject: FEA

Sickle Cell Education Centre Dishes Out Last Quarter 2021 Edition of Sickle Cell News


LAGOS, Nigeria, Nov. 18, 2021 /PRNewswire/ -- The Sickle Cell Education Centre (SCEC), which gives free access to past, current and future editions of Sickle Cell News has published and released to the public the last edition for 2021. This edition is informative, educational and useful for global SCD sensitization as other editions before it. The world's most-commonly inherited blood condition, Sickle Cell affects millions globally. Although it has no racial boundaries, the majority of affected individuals are Africans at home and in Diaspora.

Here is a refresher to some of the stories in the last quarter edition of Sickle Cell News:

According to the US National Center for Biotechnology Information (NCBI) a branch of the US National Library of Medicine (NLM), Near-Death Experiences and Outside The Body Experiences are not unknown among children and adults who have suffered traumatic events such as accidents and near-drowning. A unique inherited blood condition, sickle cell oftentimes demonstrates its power by plunging those affected with it into severe sudden generalized or localized body pains known as sickle cell crises. At these moments, death may be close at hand if treatment is not swiftly initiated. On hospital bed, some Sickle Cell Warriors have had Near-Death Experiences (NDEs) and Outside The Body Experiences (OBEs).

Two sickle cell warriors tell of their experiences on the last quarter edition of Sickle Cell News: one while in the stranglehold of severe illness, the other while performing a prescribed psychological exercise to raise his level of consciousness.

Generally a benign health condition, having Sickle Cell Trait (SCT) can occasionally be a heavy burden. A Zambian, UK-born SCT activist tells of her unenviable grapple with a condition medical science largely considers benign. An estimated 300 million people worldwide have SCT and increasing research evidence indicates that SCT may, in some individuals bring on symptoms resembling full-blown sickle cell anaemia, apart from susceptibility to certain cancers.

With reference to cancer and sickle cell, an African phytoceutical, sorghum bicolor, found to be high in polyphenols, was recently listed in the US Cancer Institute's Dictionary, signaling a possible adjunct to orthodox cancer treatment. Long known in sickle cell management in Africa, sorghum bicolor thwarts the need for repeated blood transfusion, a common thread among children and adults with sickle cell anaemia.

As the Covid-19 pandemic rages on, the SCDAA's MARAC has enjoined people with sickle cell to keep being watchful and to submit to taking all necessary vaccine doses. As a unique inheritance weakening the performance of red blood cells, SCD makes affected individuals susceptible to infections. Their immunosuppression is comparable with that in diabetes, cancer, heart disease, HIV and other debilitating ailments. In most countries, priority is given to citizens with compromised immunity, SCD inclusive.

Access to Sickle Cell News editions is available on SCEC at https://sicklecelleducationcentre.com.ng

Media Contact:

Ayoola Olajide
Editor
2348182721386
[email protected]

SOURCE Sickle Cell


These press releases may also interest you

at 13:27
In a recent study by Valisure LLC, alarming levels of benzene were found in benzoyl peroxide products commonly used to treat acne in teenagers. Benzene, a known carcinogen, poses serious health risks when exposed to high levels. The Valisure study...

at 13:23
(Family Features) Before the advent of antibiotics, infectious diseases, such as pneumonia, tuberculosis and diphtheria, were the most common causes of death in the industrialized world. Today, heart disease is the leading cause of death in the...

at 13:23
(Family Features) As a pet parent, you know your pet's needs are continually evolving. That's true during different stages of growth and even as the seasons change....

at 13:19
A substance use disorder (SUD) is a complex and often stigmatized health condition that affects countless individuals, families and communities. Stigma against people with a SUD extends beyond individual and interpersonal levels. The Shatterproof...

at 12:59
More than 400 members of the myasthenia gravis (MG) rare disease community will come together this week at the MGFA National Patient Conference for support and a better understanding of how to manage their disease while learning about the latest...

at 12:36
Kedrion Biopharma Inc., an international biopharmaceutical company specializing in the research and development, production, and commercialization of plasma-derived therapeutic products used in treating rare and serious diseases, announced today that...



News published on and distributed by: